Floatz logo

Cediranib

Weight Loss

City of Hope Medical CenterSmall moleculePhase 1Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
81/ 100

Competitive context

7 Active assets in the Weight Loss cohort.

Asset / SponsorPhaseRating
Wellbutrin
Mayo Clinic
Phase 4B
DEXAMETHASONE
M.D. Anderson Cancer Center
Phase 2B
Xeomin®
Tan Tock Seng Hospital
Phase 2/3CCC
Bacitracin
Assaf Harofeh MC
N/AD
NEOMYCIN
Assaf Harofeh MC
N/AD

View all 9 →

Same molecule, other indications

Cediranib is also rated in:

gliosarcomaDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent NeuroblastomaDormant
BBB
Indicative ·
73 / 100
View asset →
Recurrent Colon CancerDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →